Cargando…

Hsa-miR-105-1 Regulates Cisplatin-Resistance in Ovarian Carcinoma Cells by Targeting ANXA9

PURPOSE: Cisplatin is one of the most effective drugs for treating ovarian carcinoma (OC), which is among the most lethal types of carcinoma. However, the chemoresistance to cisplatin that develops over time leads to a poor clinical outcome for many OC patients. Therefore, it is necessary to clearly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kou, Xinxin, Ding, Hui, Li, Lei, Chao, Hongtu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929659/ https://www.ncbi.nlm.nih.gov/pubmed/33680718 http://dx.doi.org/10.1155/2021/6662486

Ejemplares similares

Hsa-miR-520d Converts Fibroblasts into CD105+ Populations
por: Ishihara, Yoshitaka, et al.
Publicado: (2014)

Role of hsa-miR-105 during the pathogenesis of paclitaxel resistance and its clinical implication in ovarian cancer
por: Li, Mao, et al.
Publicado: (2021)

miR-186-ANXA9 signaling inhibits tumorigenesis in breast cancer
por: Wang, Zhongrui, et al.
Publicado: (2023)

Differential expression of hsa-miR-221, hsa-miR-21, hsa-miR-135b, and hsa-miR-29c suggests a field effect in oral cancer
por: Lopes, Camile B., et al.
Publicado: (2018)

Caseinolytic protease P (CLPP) activated by ONC201 inhibits proliferation and promotes apoptosis in human epithelial ovarian cancer cells by inducing mitochondrial dysfunction
por: Kou, Xinxin, et al.
Publicado: (2021)

The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression
por: Wu, Weining, et al.
Publicado: (2019)

Hsa_circ_0063804 enhances ovarian cancer cells proliferation and resistance to cisplatin by targeting miR-1276/CLU axis
por: You, Jun, et al.
Publicado: (2022)

hsa_circ_102559 Acts as the Sponge of miR-130a-5p to Promote Hepatocellular Carcinoma Progression Through Regulation of ANXA2
por: Li, Junjian, et al.
Publicado: (2020)

CeRNA network identified hsa-miR-17-5p, hsa-miR-106a-5p and hsa-miR-2355-5p as potential diagnostic biomarkers for tuberculosis
por: Song, Jie, et al.
Publicado: (2023)

Qualitative and quantitative assessment of sperm miRNAs identifies hsa-miR-9-3p, hsa-miR-30b-5p and hsa-miR-122-5p as potential biomarkers of male infertility and sperm quality
por: Joshi, Meghali, et al.
Publicado: (2022)

“Seed-Milarity” Confers to hsa-miR-210 and hsa-miR-147b Similar Functional Activity
por: Bertero, Thomas, et al.
Publicado: (2012)

The Role of the SOX9/lncRNA ANXA2P2/miR-361-3p/SOX9 Regulatory Loop in Cervical Cancer Cell Growth and Resistance to Cisplatin
por: He, Shasha, et al.
Publicado: (2022)

Roles of hsa-miR-12462 and SLC9A1 in acute myeloid leukemia
por: Jia, Yan, et al.
Publicado: (2020)

MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME)
por: Petty, Robert D., et al.
Publicado: (2016)

Expression Analysis of hsa-miR-181a-5p, hsa-miR-143-3p, hsa-miR-132-3p and hsa-miR-23a-3p as Biomarkers in Colorectal Cancer—Relationship to the Body Mass Index
por: Tesolato, Sofía Elena, et al.
Publicado: (2023)

Elevated Circulating hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b in Type 2 Diabetes Mellitus with Diarrhea-Predominant Irritable Bowel Syndrome
por: Tao, Wenhua, et al.
Publicado: (2016)

MiR‑221 and miR‑222 regulate cell cycle progression and affect chemosensitivity in breast cancer by targeting ANXA3
por: Kim, Ju-Yeon, et al.
Publicado: (2023)

Diagnostic Significance of hsa-miR-21-5p, hsa-miR-192-5p, hsa-miR-155-5p, hsa-miR-199a-5p Panel and Ratios in Hepatocellular Carcinoma on Top of Liver Cirrhosis in HCV-Infected Patients
por: Eldosoky, Mona A., et al.
Publicado: (2023)

Interference of Hsa_circ_0003928 Alleviates High Glucose-Induced Cell Apoptosis and Inflammation in HK-2 Cells via miR-151-3p/Anxa2
por: An, Ling, et al.
Publicado: (2020)

Hsa-miR-557 Inhibits Osteosarcoma Growth Through Targeting KRAS
por: Qiao, Zhi, et al.
Publicado: (2022)

Epigenetic inactivation of the hsa-miR-203 in haematological malignancies
por: Chim, Chor Sang, et al.
Publicado: (2011)

hsa-miR-3177-5p and hsa-miR-3178 Inhibit 5-HT1A Expression by Binding the 3′-UTR Region in vitro
por: Wu, Xue, et al.
Publicado: (2019)

miR-4461 Regulates the Proliferation and Metastasis of Ovarian Cancer Cells and Cisplatin Resistance
por: Dou, Lei, et al.
Publicado: (2021)

Hsa_circ_0020095 Promotes Oncogenesis and Cisplatin Resistance in Colon Cancer by Sponging miR-487a-3p and Modulating SOX9
por: Sun, Yanlai, et al.
Publicado: (2021)

Potential role of miR-9 and miR-223 in recurrent ovarian cancer
por: Laios, Alexandros, et al.
Publicado: (2008)

Hsa-let-7c-5p, hsa-miR-130b-3p, and hsa-miR-142-3p as Novel miRNA Biomarkers for Melanoma Progression
por: Wu, Xuerui, et al.
Publicado: (2022)

hsa_circ_0081143 promotes cisplatin resistance in gastric cancer by targeting miR-646/CDK6 pathway
por: Xue, Minghui, et al.
Publicado: (2019)

SOX2 mediates cisplatin resistance in small‐cell lung cancer with downregulated expression of hsa‐miR‐340‐5p
por: Cui, Fei, et al.
Publicado: (2020)

The novel microRNAs hsa-miR-nov7 and hsa-miR-nov3 are over-expressed in locally advanced breast cancer
por: Poduval, Deepak, et al.
Publicado: (2020)

hsa-miR-518-5p/hsa-miR-3135b Regulates the REL/SOD2 Pathway in Ischemic Cerebral Infarction
por: Zhao, Boyan, et al.
Publicado: (2022)

Identification of hsa-miR-619-5p and hsa-miR-4454 in plasma-derived exosomes as a potential biomarker for lung adenocarcinoma
por: Feng, Linxiang, et al.
Publicado: (2023)

Hsa-miR-34b/c rs4938723 T>C and hsa-miR-423 rs6505162 C>A Polymorphisms Are Associated with the Risk of Esophageal Cancer in a Chinese Population
por: Yin, Jun, et al.
Publicado: (2013)

Impact Analysis of miR-1253 on Lung Cancer Progression Through Targeted Regulation of ANXA3
por: Liu, Qiang, et al.
Publicado: (2021)

miR-873 and miR-105-2 May Affect the Tumour Microenvironment and are Potential Biomarkers for Lung Adenocarcinoma
por: Zhang, Hao, et al.
Publicado: (2022)

miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer
por: Li, Hao-Yi, et al.
Publicado: (2017)

Novel small RNA expression libraries uncover hsa-miR-30b and hsa-miR-30c as important factors in anoikis resistance
por: Moreno-Mateos, Miguel A., et al.
Publicado: (2013)

Gestational Diabetes Mellitus Regulatory Network Identifies hsa-miR-145-5p and hsa-miR-875-5p as Potential Biomarkers
por: Zamanian Azodi, Mona, et al.
Publicado: (2019)

hsa-miR-96 and hsa-miR-217 Expression Down-Regulates with Increasing Dysplasia in Pancreatic Intraepithelial Neoplasias and Intraductal Papillary Mucinous Neoplasms
por: Chang, XiaoYan, et al.
Publicado: (2017)

Correction: The novel microRNAs hsa-miR-nov7 and hsa-miR-nov3 are over-expressed in locally advanced breast cancer
por: Poduval, Deepak, et al.
Publicado: (2021)

miR-105 Promotes the Progression and Predicts the Prognosis for Oral Squamous Cell Carcinoma (OSCC)
por: Zhang, Hong-Yu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nj975dfsc5dka0pchfnuml5qra